Is Hypoxemia Driving Outcome in Acute Hypoxemic Respiratory Failure? (HOMELAND Study)
HOMELAND
Is the Degree of Hypoxemia Driving Outcome or is it a Marker of Overall Organ Dysfunction in Acute Hypoxemic Respiratory Failure?
1 other identifier
observational
1,241
2 countries
18
Brief Summary
Acute hypoxemic respiratory failure (AHRF) is the most common cause of admission in the intensive care units (UCIs) worldwide. The investigators will assess the value of mediation analysis (a statistical method to understand the mechanism or process through which an independent variable influences a dependent variable (prediction of early ICU death) via a mediator variable. This allows researcher to see the "how" and "why" of a causal link, respecting the timing relationships" o "maintaining appropriate time constants in patients with AHRF me, We had a database with 2,000,000 anonymized and dissociated demographics and clinical data from 1,241 patients with AHRF enrolled in our PANDORA cohort (Prevalence AND Outcome of acute Respiratory fAilure) registered with ClinicalTrails.gov (NCT013145974) from 22 Spanish hospitals and funded by the ISCIII. The study was approved by the Ethics Committees for Clinical research of participating hospitals and informed consent was waived based on Spanish legislation for biomedical research (Royal Decrees 1090/2015 and 957/2020). The investigators will use mediation analysis (Baron \& Kenny techniques) to clarify the association of extrapulmonary organ dysfunction and hypoxemia in the early prediction of ICU mortality. We will analyze 1,241 patients mechanically ventilated with AHRF at the time of diagnosis, 1,193 with data at 24 hours, and 996 patients with data at 48 hours from a epidemiological study in Spain.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for all trials
Started Jul 2026
18 active sites
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
July 13, 2026
CompletedStudy Start
First participant enrolled
July 13, 2026
CompletedFirst Posted
Study publicly available on registry
July 16, 2026
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 29, 2027
ExpectedStudy Completion
Last participant's last visit for all outcomes
July 29, 2027
July 17, 2026
July 1, 2026
1 year
July 13, 2026
July 16, 2026
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Death in the intensive care unit (ICU)
prediction of ICU death
up to 100 weeks
Study Arms (3)
Time on admission
The investigators will use 1241 at the time of meeting AHRF (t0)
Time 24
The investigaotros will use 1193 patients with AHRF, with completed data after 24 hours of mechanical ventilation
Time 48
The investigaotros will use 996 patients with AHRF with completed data after 48 hours of mechanical ventilation
Interventions
This allows researcher to see the "how" and "why" of a causal link, respecting the timing relationships" o "maintaining appropriate time constants in patients with AHRF mechanically ventilated.
Eligibility Criteria
Critically ill patients, intubated and mechanically ventilated, with acute hupoxemic respiratory failure (AHRF)
You may qualify if:
- intubation and mechanical ventilation PaO2/FiO2 ratio \< or = 300 mmHg under MV with PEEP \> or = 5 cmH2O, and FiO2 \> 0r = 0.3
You may not qualify if:
- Brain death patients
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Jesus Villarlead
- Hospital Universitario de Gran Canaria Doctor Negríncollaborator
Study Sites (18)
Department of Anesthesia, Hospital Universitario de Cruces
Barakaldo, Vizcaya, 48903, Spain
Complejo Hospitalario Universitario de Albacete (ICU)
Albacete, 02006, Spain
Hospital Clinic de Barcelona (AVI)
Barcelona, 08036, Spain
Hospital Clínic de Barcelona (Anesthesia)
Barcelona, 08036, Spain
Hospital Clinic
Barcelona, Spain
Complejo Asistencial Universitario de León (ICU)
León, 24001, Spain
Complejo Hospitalario Universitario de León
León, Spain
Department of Anesthesia, Hospital Universitario La Paz
Madrid, 28046, Spain
Department of Anesthesia, Hospital Universitario Virgen de Arrixaca
Murcia, 30120, Spain
Department of Anesthesia, Hospital Clinico Universitario
Valencia, 46010, Spain
Hospital Cinico de Valencia
Valencia, 46010, Spain
Hospital Clinico Universitario de Valencia (Anesthesia)
Valencia, 46010, Spain
Hospital Clinico de Valencia
Valencia, Spain
Hospital Clínico Universitario de Valencia
Valencia, Spain
Department of Anesthesia, Hospital Clínico Universitario
Valladolid, 47003, Spain
Anesthesia, Hospital Universitario Río Hortega
Valladolid, 47012, Spain
Hospital Clínico Universitario de Valladolid
Valladolid, Spain
Cardiff University
Cardiff, United Kingdom
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- STUDY CHAIR
Jesus Villar
Research Unit, Hospital Universitario Dr. Negrín, Las Palmas de Gran Canaria, Spain
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Principal investigator and scientificc advisor
Study Record Dates
First Submitted
July 13, 2026
First Posted
July 16, 2026
Study Start
July 13, 2026
Primary Completion (Estimated)
July 29, 2027
Study Completion (Estimated)
July 29, 2027
Last Updated
July 17, 2026
Record last verified: 2026-07
Data Sharing
- IPD Sharing
- Will not share